Cargando…

Mass spectrometry detection of inhaled drug in distal fibrotic lung

BACKGROUND: Currently the only available therapies for fibrotic Interstitial Lung Disease are administered systemically, often causing significant side effects. Inhaled therapy could avoid these but to date there is no evidence that drug can be effectively delivered to distal, fibrosed lung. We set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mikolasch, Theresia A., Oballa, Eunice, Vahdati-Bolouri, Mitra, Jarvis, Emily, Cui, Yi, Cahn, Anthony, Terry, Rebecca L., Sahota, Jagdeep, Thakrar, Ricky, Marshall, Peter, Porter, Joanna C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092847/ https://www.ncbi.nlm.nih.gov/pubmed/35546672 http://dx.doi.org/10.1186/s12931-022-02026-5

Ejemplares similares

Identification of a Novel HIF-1α-α(M)β(2) Integrin-NET Axis in Fibrotic Interstitial Lung Disease
por: Khawaja, Akif A., et al.
Publicado: (2020)

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
por: Maher, Toby M., et al.
Publicado: (2020)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
por: Usmani, Omar S., et al.
Publicado: (2018)

Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis
por: Chong, Deborah L. W., et al.
Publicado: (2023)

Inhaler devices and their challenges - Helping patients use inhalers
por: Chawhan, Ashwini, et al.
Publicado: (2023)

Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes
por: Mercer, Robert R, et al.
Publicado: (2013)

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD
por: Rheault, Tara, et al.
Publicado: (2016)

Mucins and their receptors in chronic lung disease
por: Denneny, Emma, et al.
Publicado: (2020)

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
por: Maltais, François, et al.
Publicado: (2019)

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD
por: Feldman, Gregory, et al.
Publicado: (2016)

Interpreting patient-reported outcomes from clinical trials in COPD: a discussion
por: Jones, Paul W, et al.
Publicado: (2016)

Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
por: Khor, Yet H., et al.
Publicado: (2022)

Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbits
por: Pennypacker, Brenda L, et al.
Publicado: (2013)

Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD
por: Singh, Sally, et al.
Publicado: (2018)

Update on new biologics for intractable eosinophilic asthma: impact of reslizumab
por: Sahota, Jagdeep, et al.
Publicado: (2018)

Diagnosis of Fibrotic Distal Ileum Stenosis after Ischemic Enteritis Using Transabdominal Ultrasonography
por: Katsumata, Ryo, et al.
Publicado: (2021)

The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkers
por: Kalinke, Lukas, et al.
Publicado: (2020)

Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis
por: Ito, Yasuhiro, et al.
Publicado: (2022)

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler
por: Prime, David, et al.
Publicado: (2015)

Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
por: Lee, Cathryn T., et al.
Publicado: (2022)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

Genetically modified mesenchymal stromal cells in cancer therapy
por: Sage, Elizabeth K., et al.
Publicado: (2016)

A vasculature niche orchestrates stromal cell phenotype through PDGF signaling: Importance in human fibrotic disease
por: Layton, Thomas B., et al.
Publicado: (2022)

Identification of a distal RXFP1 gene enhancer with differential activity in fibrotic lung fibroblasts involving AP-1
por: Chen, Ting-Yun, et al.
Publicado: (2021)

Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
por: Vanderstichele, Sophie, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease patients’ experience using Trelegy as compared with other inhalers
por: Mashaal, Hyfaa, et al.
Publicado: (2022)

Spatially resolved deconvolution of the fibrotic niche in lung fibrosis
por: Eyres, Michael, et al.
Publicado: (2022)

Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes
por: Mercer, Robert R, et al.
Publicado: (2011)

Pro-fibrotic SNPs
por: Maxmen, Amy
Publicado: (2009)

Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
por: Iwata, Yasunori, et al.
Publicado: (2021)

Amphitrite: A program for processing travelling wave ion mobility mass spectrometry data
por: Sivalingam, Ganesh N., et al.
Publicado: (2013)

Novel Bioimaging Techniques of Metals by Laser Ablation Inductively Coupled Plasma Mass Spectrometry for Diagnosis Of Fibrotic and Cirrhotic Liver Disorders
por: M-M, Pornwilard, et al.
Publicado: (2013)

Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis
por: Mikolasch, Theresia A., et al.
Publicado: (2022)

Proteomics approaches to fibrotic disorders
por: Gucek, Marjan
Publicado: (2012)

Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017)

T Cells in Fibrosis and Fibrotic Diseases
por: Zhang, Mengjuan, et al.
Publicado: (2020)

Mitochondrial dysfunction in fibrotic diseases
por: Li, Xinyu, et al.
Publicado: (2020)

Fibrotic Scar in Neurodegenerative Diseases
por: D'Ambrosi, Nadia, et al.
Publicado: (2020)

Role of Ferroptosis in Fibrotic Diseases
por: Zhou, Jian, et al.
Publicado: (2022)

Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging
por: Zecchi, Riccardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6toctcrdkob3tb2nqli9n47ju